RIKA: Outcome After Revisions of Infected Knee Arthroplasties

Sponsor
Odense University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04427943
Collaborator
(none)
350
8
84
43.8
0.5

Study Details

Study Description

Brief Summary

A prospective multicenter cohort study on all types of revision knee arthroplasty procedures performed due to infection.

Condition or Disease Intervention/Treatment Phase
  • Procedure: revision surgery

Detailed Description

A prospective multicenter cohort study on all types of revision knee arthroplasty procedures performed due to infection.

Most previous studies investigating outcomes after revisions of infected knee artrplasties are single-center studies and retrospective. The study group has previously investigated outcome of the surgical treatment of infected knee arthroplasties in Denmark based on nationwide data from Danish registries. These studies revealed that the risk of treatment failure causing re-revision or mortality was 30-40% in Denmark.

Based on these findings, an ongoing randomized controlled trial "one-stage versus two-stage revisions of the infected knee arthroplasty" (ClinicalTrials.gov ID: NCT03435679) has been initiated by the study group in Febuary 2018. It has been possible to include 20% of the patients with surgically demanding periprosthetic knee infections from the including centres in this randomized trial due to in- and exclusions criteria. Hence, the investigators wish to include the remaining patients with periprosthetic knee joint infection in a prospective cohort study in order to obtain high quality prospective data on function, quality of life and complications after all types of surgical procedures performed due to periprosthetic knee joint infection. Based on these data it will be possible to evaluate the surgical treatment overall and it will be possible to evaluate whether the patients included in the randomized trial are representative.

Study aim:

To present patient reported outcome and postoperative complications after all types of surgical procedures performed due to periprosthetic knee infection. Furthermore, to analyze the role of potential risk factors (patient comorbidity, microbiological diagnosis, surgical intervention, antibiotic treatment, duration of symptoms) on outcome of the patients.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
350 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Outcome After Revisions of Infected Knee Arthroplasties - a Prospective Multicenter Cohort Study
Actual Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
Jan 1, 2027

Arms and Interventions

Arm Intervention/Treatment
RIKA cohort

patients with periprosthetic knee joint infection scheduled for revision knee arthroplasty surgery

Procedure: revision surgery
The intervention is the planned revision surgery according to local guidelines.

Outcome Measures

Primary Outcome Measures

  1. Change in Oxford Knee Score (Area Under Curve (AUC) from preoperatively to 12 months postoperatively) [Measured preoperatively 6 weeks, 3, 6, 9, 12 months postoperatively]

    Change in Oxford Knee Score from preoperatively to 12 months postoperatively measured as Area Under Curve. Oxford Knee Score ranges from 0 to 48, 48 = best score.

Secondary Outcome Measures

  1. Change in Oxford Knee Score (Area Under Curve, AUC from preop. to 12 months postop.) [Time Frame: Measured preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively]

    Change in Oxford Knee Score from preoperatively to 24 months postoperatively measured as Area Under Curve. Oxford Knee Score ranges from 0 to 48, 48 = best score.

  2. Change in EuroQol five-dimensional descriptive system (EQ-5D-5L) from preop to 24 months postop. [Measured preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively.]

    Quality of life questionnaire

  3. Number of participants re-revised (re-revision rate) [2 year postoperatively]

    Number of patients re-revised due to infection and other causes within 2 years postoperatively.

  4. Number of participants dying (mortality rate) [2 years postoperatively]

    Number of participants dying within 2 years posoperatively

  5. Number of participants readmitted (readmission rate) [90 days postoperatively]

    Number of participant readmitted within 90 days postoperatively

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Clinical signs of periprosthetic knee joint infection and indication for revision surgery

  • Speak and understand Danish and have given informed consent

Exclusion Criteria:
  • Participation in "one-stage versus two-stage revisions of the infected knee arthroplasty"

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aalborg University Hospital Aalborg Denmark
2 Bispebjerg Hospital Copenhagen Denmark
3 Hvidovre Copenhagen Denmark
4 Rigshospitalet Copenhagen Denmark
5 Horsens Hospital Horsens Denmark
6 Næstved Hospital Næstved Denmark
7 Odense Universitets Hospital Odense Denmark
8 Vejle Hospital Vejle Denmark

Sponsors and Collaborators

  • Odense University Hospital

Investigators

  • Principal Investigator: Martin Lindberg-Larsen, MD, PhD, Odense University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Martin Lindberg-Larsen, Principal investigator, Odense University Hospital
ClinicalTrials.gov Identifier:
NCT04427943
Other Study ID Numbers:
  • S-20170108/69984
First Posted:
Jun 11, 2020
Last Update Posted:
Aug 27, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Martin Lindberg-Larsen, Principal investigator, Odense University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 27, 2021